Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2007 4
2009 2
2010 1
2013 1
2015 4
2017 4
2018 1
2019 2
2020 4
2021 3
2022 5
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Vompersky
Page 1
Trial of Intravenous Immune Globulin in Dermatomyositis.
Aggarwal R, Charles-Schoeman C, Schessl J, Bata-Csörgő Z, Dimachkie MM, Griger Z, Moiseev S, Oddis C, Schiopu E, Vencovský J, Beckmann I, Clodi E, Bugrova O, Dankó K, Ernste F, Goyal NA, Heuer M, Hudson M, Hussain YM, Karam C, Magnolo N, Nelson R, Pozur N, Prystupa L, Sárdy M, Valenzuela G, van der Kooi AJ, Vu T, Worm M, Levine T; ProDERM Trial Group. Aggarwal R, et al. N Engl J Med. 2022 Oct 6;387(14):1264-1278. doi: 10.1056/NEJMoa2117912. N Engl J Med. 2022. PMID: 36198179 Clinical Trial.
Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis.
Baeten D, Sieper J, Braun J, Baraliakos X, Dougados M, Emery P, Deodhar A, Porter B, Martin R, Andersson M, Mpofu S, Richards HB; MEASURE 1 Study Group; MEASURE 2 Study Group. Baeten D, et al. N Engl J Med. 2015 Dec 24;373(26):2534-48. doi: 10.1056/NEJMoa1505066. N Engl J Med. 2015. PMID: 26699169 Free article. Clinical Trial.
Olokizumab versus Placebo or Adalimumab in Rheumatoid Arthritis.
Smolen JS, Feist E, Fatenejad S, Grishin SA, Korneva EV, Nasonov EL, Samsonov MY, Fleischmann RM; CREDO2 Group. Smolen JS, et al. N Engl J Med. 2022 Aug 25;387(8):715-726. doi: 10.1056/NEJMoa2201302. N Engl J Med. 2022. PMID: 36001712 Clinical Trial.
Progressive hemifacial atrophy: a review.
Tolkachjov SN, Patel NG, Tollefson MM. Tolkachjov SN, et al. Orphanet J Rare Dis. 2015 Apr 1;10:39. doi: 10.1186/s13023-015-0250-9. Orphanet J Rare Dis. 2015. PMID: 25881068 Free PMC article. Review.
Comparison of simple expression procedures in novel expression host Vibrio natriegens and established Escherichia coli system.
Kormanová Ľ, Rybecká S, Levarski Z, Struhárňanská E, Levarská L, Blaško J, Turňa J, Stuchlík S. Kormanová Ľ, et al. J Biotechnol. 2020 Sep 10;321:57-67. doi: 10.1016/j.jbiotec.2020.06.003. Epub 2020 Jun 23. J Biotechnol. 2020. PMID: 32589894 Review.
Our results have shown that cultures of V. natriegens using sucrose as a main carbon source can be used for the production of industrially applicable proteins, where it offers higher biomass productions compared to E. coli. In case of human growth hormone production, produ …
Our results have shown that cultures of V. natriegens using sucrose as a main carbon source can be used for the production of industrially a …
Effects of diet on skin sensitization by nickel, poison ivy, and sesquiterpene lactones.
An N, Pourzal S, Luccioli S, Vukmanović S. An N, et al. Food Chem Toxicol. 2020 Mar;137:111137. doi: 10.1016/j.fct.2020.111137. Epub 2020 Jan 23. Food Chem Toxicol. 2020. PMID: 31982450 Review.
Skin contact or exposure to sensitizers often occurs as a consequence of occupational exposures (e.g. poison ivy in forestry), wearing jewelry (e.g. nickel), or use of cosmetics (e.g. fragrances). ...
Skin contact or exposure to sensitizers often occurs as a consequence of occupational exposures (e.g. poison ivy in forestry), wearin …
Large Deviations for Continuous Time Random Walks.
Wang W, Barkai E, Burov S. Wang W, et al. Entropy (Basel). 2020 Jun 22;22(6):697. doi: 10.3390/e22060697. Entropy (Basel). 2020. PMID: 33286470 Free PMC article.
Under mild conditions that the microscopic jump lengths distribution is decaying exponentially or faster i.e., Levy like power law distributed jump lengths are excluded, and that the distribution of the waiting times is analytical for short waiting times, the spreading of …
Under mild conditions that the microscopic jump lengths distribution is decaying exponentially or faster i.e., Levy like power law di …
35 results